Australia TGA ARTG recordiStent inject® W System ( Model G2-W). - Glaucoma micro-stent
Australia TGA ARTG Registered Device · RQSolutions Medical Devices Distribution Support · Glaukos Corporation · Class III · Started August 09, 2019
Good Name: RQSolutions Medical Devices Distribution Support - iStent inject® W System ( Model G2-W). - Glaucoma micro-stent
- Risk Class
- Class III
- Product Type
- Single Device Product
- ARTG Category
- General
- Start Date
- August 09, 2019
- Effective Date
- August 09, 2019
- Country
- United States of America
- Address
- 229 Avenida Fabricante, San Clemente, CA, 92672
The iStent inject W System Trabecular Micro-Bypass System is intended to reduce intraocular pressure in adult patients diagnosed with mild to moderate primary open-angle glaucoma (POAG) currently treated with ocular hypotensive medication. The device can be implanted with or without cataract surgery
Access comprehensive regulatory information for iStent inject® W System ( Model G2-W). - Glaucoma micro-stent in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is sponsored by RQSolutions Medical Devices Distribution Support, manufactured by Glaukos Corporation in United States of America. The device registration started on August 09, 2019.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.